The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 16, 2024
Filed:
Mar. 30, 2023
Applicant:
Belhaven Biopharma Inc., Raleigh, NC (US);
Inventors:
Scott Lyman, Raleigh, NC (US);
Barry Bleske, Albuquerque, NM (US);
Ted William Lanpher, Half Moon Bay, CA (US);
Assignee:
BELHAVEN BIOPHARMA INC., Durham, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/02 (2006.01); A61K 31/137 (2006.01); A61K 47/38 (2006.01); A61K 31/417 (2006.01); A61K 31/277 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0075 (2013.01); A61K 9/0043 (2013.01); A61K 31/137 (2013.01); A61K 31/277 (2013.01); A61K 31/417 (2013.01); A61K 47/02 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01);
Abstract
Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening conditions.